Rakesh Verma

Head Immuno-Oncology Clinical Development


Novateur Advisor Since



Immuno-Oncology, Clinical Development


Business Development, Oncology & Immuno-Oncology

“We firmly believe in providing support from the ground-up to founders and companies, to help build a data-based approach to bring solutions for unmet clinical needs and create value for our patient community.”

Rakesh Verma
Head Immuno-Oncology Clinical Development

Rakesh Verma is a Drug development & Clinical Translational Leader with more than 15 years of experience in immuno-oncology, hematology, and oncology. Rakesh most recently led ARMO Biosciences as Site-Head and drove the successful M&A of ARMO ($1.6 Bn) with Eli Lilly. Rakesh has led IND development of Cytokine-based drug development at Eli Lilly as their VP level executive for early phase development. He is a highly adaptable scientific leader with a proven record of dealing with rapid growth and development. He works effectively with the scientific and executive teams using data and problem-solving techniques to support the strategic vision of the organization.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!